• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virus Evol . Identification and genomic characterization of BA.3.2: a highly divergent BA.3-related SARS-CoV-2 lineage from southern Africa

tetano

Editor, Senior Moderator
Virus Evol


. 2026 Mar 18;12(1):veag016.
doi: 10.1093/ve/veag016. eCollection 2026.
Identification and genomic characterization of BA.3.2: a highly divergent BA.3-related SARS-CoV-2 lineage from southern Africa

Graeme Dor[SUP] 1 [/SUP], Dikeledi Kekana[SUP] 2 [/SUP], Ryan Hisner[SUP] 3 [/SUP], Darren P Martin[SUP] 3 [/SUP], Bette Korber[SUP] 4 5 [/SUP], Timo Ernst[SUP] 6 7 [/SUP], Avram Levy[SUP] 6 7 [/SUP], David Speers[SUP] 6 8 [/SUP], Stuart Turville[SUP] 9 [/SUP], Vitali Sintchenko[SUP] 10 [/SUP], Kerri Basile[SUP] 10 [/SUP], Geraldine Sullivan[SUP] 10 [/SUP], Rebecca Rockett[SUP] 10 [/SUP], Jen Kok[SUP] 10 [/SUP], Josette Schoenmakers[SUP] 11 [/SUP], Federico Gueli[SUP] 12 [/SUP], Richard Lessels[SUP] 13 [/SUP], Cheryl Baxter[SUP] 1 [/SUP], Nicole Wolter[SUP] 2 14 [/SUP], Anne von Gottberg[SUP] 2 14 [/SUP], Houriiyah Tegally[SUP] 1 [/SUP], Tulio de Oliveira[SUP] 1 13 [/SUP]


Affiliations
Abstract

In November 2024, a highly divergent BA.3-related severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage, designated BA.3.2, was detected in South Africa, marking the first appearance of a BA.3-derived lineage in over 2 years. Phylogenetic reconstruction places BA.3.2 on an extended branch descending from ancestral BA.3, with no intermediate genomes detected, consistent with a prolonged period of unsampled or isolated evolution. Molecular clock analyses indicate accelerated divergence characteristic of a saltation event, whilst phylogeographic and demographic analyses point to a southern African origin followed by multiple independent exportations and evidence of ongoing global transmission. Relative to ancestral BA.3, BA.3.2 harbours 39 amino acid substitutions in the spike glycoprotein, two N-terminal domain deletions (Δ136-147 and Δ243-244), a four-residue insertion (ins214:ASDT), and a large deletion spanning ORF7a, ORF7b, and ORF8. The co-occurrence of D405N and R408S implies epistasis between these sites, whilst reversions R493Q and H505Y likely enhance ACE2 binding and antibody escape. Extensive remodelling across the spike, including loss of the C15-C136 disulphide bond and substitutions in the SD1 and SD2 domains, may influence spike stability, cleavage, and fusogenicity. The emergence and continued circulation of BA.3.2 underscores the ongoing potential for highly divergent SARS-CoV-2 variants to arise and spread globally. Despite its limited prevalence, the persistence of BA.3.2 alongside dominant lineages, together with evidence of more recent expansion, indicate that this lineage retains the potential to become of epidemiological concern under favourable conditions.

Keywords: BA.3.2; SARS-CoV-2; omicron; phylogenetics; viral evolution.

 
Back
Top